OEM News

Convatec Introduces Co-Branded eakin freeseal Ostomy Seal in North America

The new seal can absorb up to four times its weight in fluid without breaking down underneath the skin barrier.

The eakin freeseal air (left) and eakin freeseal versa (right). Photos: Eakin Healthcare.

Convatec and Eakin Healthcare have launched eakin freeseal, the thinnest ostomy seal built to help prevent leaks and protect the skin around a stoma. This new co-branded seal is part of the ESENTA product line, available in the United States.

Ostomy seals are designed to create a protective layer around the stoma to prevent leaks. Recurrent leaks can lead to skin breakdown and irritation, triggering longer-term issues, both physically and emotionally. Approximately 1 million U.S. residents live with a stoma, and about 90% experience a leak at some point.3 Using ostomy seals can reduce or eliminate leaks, leading to a better quality of life for patients.

The eakin freeseal range includes two product lines—eakin freeseal air, and eakin freeseal versa, which provide healthcare professionals with versatile options that combine discretion, comfort, and high performance. While Convatec currently addresses the patient’s needs with the eakin Cohesive seal, eakin freeseal provides healthcare professionals with a wider range of options to meet their clinical needs. The thinner offering, eakin freeseal air has a depth starting at 1.8 mm, making it the thinnest seal on the market, and is designed to be paired with convex pouches, according to the company. eakin freeseal versa is slightly thicker and designed to absorb fluid at the best rate in the market without breaking down, leading to easier removal for the end user, Convatec bigwigs claim.

The new ostomy seal’s thinness as well as its composition and design allows it to absorb up to four times its weight in fluid without breaking down underneath the skin barrier.1 This performance, combined with eakin seals’ best-in-market moldability,2 gives post-surgical stoma patients a relatable solution through eakin freeseal. Ostomy seals and barriers designed to prevent leakage and skin irritation is one of the largest product categories in the United States and continue to grow at a consistent rate.

“We are pleased to add eakin freeseal to our ESENTA family of skin-friendly accessories, expanding the range of options available to clinicians and patients, and supporting easier, more confident everyday care with our forever caring promise,” Convatec U.S. Ostomy Care Vice President Dan Yrigoyen said. “This marks a new chapter in the longstanding partnership between Convatec and Eakin Healthcare. Together we continue to advance ostomy care in line with our forever caring promise.”

Integrating eakin seals into the ESENTA range reinforces the importance of using a reliable ostomy seal as part of the customers skincare routine, the companies noted.

Eakin Healthcare is a medical device manufacturer based in Comber, Northern Ireland. Founded in 1973, pharmacist Tom Eakin saw a need to support individuals living with a stoma with better ostomy products to improve comfort, confidence, and quality of life. The company continues to build on its heritage of patient-focused innovation, combining clinical insight with advanced manufacturing to deliver reliable medical devices used worldwide. With a global presence and a focus on quality, the company works to enhance the lives of those managing complex healthcare needs.

Convatec is a global medical products and technologies company, focused on solutions for managing chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than 10,000 employees, the company provides products and services in about 90 countries. Its solutions provide a range of benefits, from infection prevention, treatment for hard-to-heal wounds, at-risk skin, and ulcerated tissue, to supporting debilitating conditions, improved patient outcomes, and reduced care costs. Convatec’s 2025 revenues were more than $2 billion. The company is a FTSE 100 Index constituent.

References
1 Mc Groggan G, Haughey S and McDowell K (2018) An absorbent, enzyme-inhibiting seal reduces peristomal skin complications. Gastrointestinal Nursing 16:1 42-4.
2 T.G. Eakin Laboratory Testing Summary report, ostomy seals 2023 (Data on file) EA-005683-ST
3 Eakin Healthcare Stoma Census 2023 n=1992. Data on file.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters